Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +44.45%
#2 Bitway Bitway +37.28%
#3 Pons Pons +37.06%
#4 Mubarak Mubarak +36.84%
#5 Ocean Protocol Ocean Protocol +34.14%
#6 Starpower Starpower +29.65%
#7 SkyAI SkyAI +21.90%
#8 Decred Decred +18.17%
#9 PondCoin PondCoin +18.16%
#10 TENDIES TENDIES +17.96%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Clasificación en acciones #29359
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Precio por acción
$0.365
Última sincronización: 2025-08-01
Capitalización bursátil
$21.54M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Elevation Oncology, Inc. (ELEV)

Categoría

Healthcare
Historial del precio de la acción de Elevation Oncology, Inc. (ELEV)
Precio más alto de cierre: $0.37 el 2025-08-01

Precio más bajo de cierre: $12.36 el 2021-06-01
Historial del precio de la acción de Elevation Oncology, Inc. desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2025 -40.93%
2024 21.56%
2023 -47.33%
2022 -81.61%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $543.65 39.13%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 55.81%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $141.86 408.28%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $117.42 -19.34%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $753.28 8.59%
CH